Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
19.41
-0.82 (-4.05%)
May 18, 2026, 4:00 PM EDT - Market closed
Syndax Pharmaceuticals Employees
Syndax Pharmaceuticals had 298 employees as of December 31, 2025. The number of employees increased by 28 or 10.37% compared to the previous year.
Employees
298
Change (1Y)
28
Growth (1Y)
10.37%
Revenue / Employee
$728,772
Profits / Employee
-$816,272
Market Cap
1.72B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 298 | 28 | 10.37% | 298 | 0 |
| Dec 31, 2024 | 270 | 86 | 46.74% | 270 | 0 |
| Dec 31, 2023 | 184 | 77 | 71.96% | 184 | 0 |
| Dec 31, 2022 | 107 | 48 | 81.36% | 107 | 0 |
| Dec 31, 2021 | 59 | 16 | 37.21% | 59 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sarepta Therapeutics | 835 |
| Ascentage Pharma Group International | 605 |
| Lakefront Biotherapeutics NV | 558 |
| Harmony Biosciences Holdings | 293 |
| Zymeworks | 264 |
| Viridian Therapeutics | 252 |
| Stoke Therapeutics | 170 |
| AnaptysBio | 104 |
SNDX News
- 5 days ago - Syndax price target lowered to $37 from $38 at UBS - TheFly
- 6 days ago - Syndax reports 12 Revuforj abstracts accepted for EHA - TheFly
- 6 days ago - Syndax Highlights 12 Revuforj® (revumenib) Abstracts Accepted for EHA 2026, Advancing Leadership in Menin Inhibition - GlobeNewsWire
- 12 days ago - Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - GlobeNewsWire
- 14 days ago - Syndax price target raised to $46 from $45 at Stifel - TheFly
- 17 days ago - Syndax price target lowered to $37 from $40 at Jefferies - TheFly
- 18 days ago - Syndax price target raised to $37 from $35 at Barclays - TheFly
- 18 days ago - Syndax Pharmaceuticals Earnings Call Transcript: Q1 2026 - Transcripts